Protopic (tacrolimus) ointment - Revised SPC

Source: Pharmaceutical Journal

Date published: 07/06/2009 20:55

Type of SPC Change: Revised SPC

Generic drug name: Tacrolimus

Drug brand name: Protopic

Legal status: POM

Pharmaceutical manufacturer: Astellas

Summary
by: Claire Christmas

Protopic is now indicated for the maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

See SPC for full details.

SPC

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.